Anti-idiotypic antibodies from highly sensitized patients stimulate B cells to produce anti-HLA antibodies

Transplantation

Volumn 73, Issue 12, 2002, Pages 1853-1858

  Hack, Nashrudeen ^a   Angra, Sarita ^a   Friedman, Eva ^a   McKnight, Theresa ^b   Cardella, Carl J ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN G; LEUKOCYTE ANTIGEN;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SENSITIZATION; TARGET CELL;

EID: 0037182845     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200206270-00001     Document Type: Article

References (30)

1. Anti-HLA antibodies after solid organ transplantation
2. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients
3. Successful renal transplantation in patients with T cell reactivity to donor
4. Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients
5. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ
6. Mechanisms of T cell recognition of alloantigen
7. Lack of enhanced T-helper cell function in uremic patients with circulating alloreactive antibodies
8. Chimerism in peripheral blood of sensitized patients waiting for renal transplantation: Clinical implications
9. Association of antiidiotypic antibody with successful second transplant of a kidney sharing HLA antigens with the previous hyperacutely rejected first kidney
10. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients
11. Structural profile of idiotype, anti-idiotype and anti-anti-idiotype monoclonal antibodies in the HLA-DQ3 antigenic system
12. Idiotypes: Structure and immunogenicity
13. The use of antiidiotypic antibodies as vaccines against infectious agents
14. Isolation of leucocytes from human blood: A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent
15. Depletion of T lymphocytes from human bone marrow: Use of magnetic monosized polymer microspheres coated with T lymphocyte specific monoclonal antibodies
16. Elimination of B lymphoma cells from human bone marrow: Model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies
17. Cross-reactive HLA antibodies. Separation from multiple HLA antibody specificities and acid elution
18. A rapid assay for von Willebrand factor
19. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus induced B-cell lines
20. HLA alloantibodies and the mechanism of antiglobulin-augmented lymphocytotoxicity procedure
21. Immunosuppressive potency and in vitro activity of antilymphocyte globulin
22. Enzyme-linked immunoassay for anti-HLA antibodies: An alternative to panel studies by lymphocytotoxicity
23. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies
24. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients
25. Elimination of alloantibodies by immunoablative high-dose cyclophosphamide
26. Chronic humoral rejection: Identification of antibody-mediated chroric renal allograft rejection by C4d deposits in peritubular capillaries
27. Molecular mimicry and autoimmunity
28. Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes
29. In vitro IgG1 alloreactive antibody production by circulating memory cells in humans